Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin EPC Mobilization in CAD
NCT00911339Phase 3Terminated
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Jan 2009
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atorvastatin in coronary artery disease (CAD), sponsored by IRCCS San Matteo Foundation. Started Jan 2009; status: terminated.
02
Drugs
atorvastatin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00911339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00911339.